Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data

Published:2023 Issue:1 Volume:18 Page:45
ISSN:1817-1737
Container-title:Annals of Thoracic Medicine
language:en
Short-container-title:Ann Thorac Med

Author:

Al-Jahdali Hamdan,Khan MohammedAyaz,Sherbini Nahed,Alyami Sami,Al-Harbi Abdullah,Al-Ghamdi Majed,Alrajhi Suliman,Rajendram Rajkumar

Publisher

Medknow

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference29 articles.

1. Focus on idiopathic pulmonary fibrosis: Advancing approaches to diagnosis, prognosis, and treatment;Martinez;Chest,2018

2. Diagnosis of idiopathic pulmonary fibrosis.An official ATS/ERS/JRS/ALAT Clinical Practice Guideline;Raghu;Am J Respir Crit Care Med,2018

3. Idiopathic pulmonary fibrosis: Lessons from clinical trials over the past 25 years;Raghu;Eur Respir J,2017

4. Idiopathic pulmonary fibrosis;Martinez;Nat Rev Dis Primers,2017

5. Predictors of mortality in interstitial lung disease patients without pulmonary hypertension;Alhamad;Ann Thorac Med,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-04

2. Integrated ML-Based Strategy Identifies Drug Repurposing for Idiopathic Pulmonary Fibrosis;ACS Omega;2024-06-27

3. Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators;World Journal of Stem Cells;2024-06-26

4. Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators;World Journal of Stem Cells;2024-06-26

5. Potential Protective Effect of Agmatine on Bleomycin-Induced Pulmonary Fibrosis in Male Albino Rats;International Journal of Pharmacology;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3